Company / Operating Cash Flow per Share
Bio-Techne Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.82
FY2025
5-year range
$1.82 / $5.27
FY2021-FY2025
Trend
-4.2%
vs FY2024
Sector context
#94 of 161
Health Care
What the data says
At $1.82, Bio-Techne's operating cash flow per share ranks #94 of 161 in the Health Care sector. Operating Cash Flow per Share has declined for 3 consecutive years, from $5.27 in FY2022 to $1.82 in FY2025.
Based on SEC 10-K filings.
1.82 in FY2025 with a 5-year CAGR of -19.6%.
Declined from $2.25 to $1.82 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -29.9%
- 5-Year CAGR
- -19.6%
- 10-Year CAGR
- -
Sector benchmark
#94 of 161 in Health CareTop 58% of 161This company $1.82 Sector average $6.67
▼
-72.8% below sector average
Key checks
Key Insights
- Bio-Techne's operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 4.2% year-over-year.
- Ranks #94 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.82 | -4.2% |
| FY2024 | $1.90 | -15.6% |
| FY2023 | $2.25 | -57.3% |
| FY2022 | $5.27 | +11.5% |
| FY2021 | $4.72 | -12.7% |
| FY2020 | $5.41 | +12.0% |
| FY2019 | $4.83 | +7.9% |
| FY2018 | $4.48 | +16.0% |
| FY2017 | $3.86 | -0.6% |
| FY2016 | $3.88 | +3.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026